Selective Changes in Lymphocytic Differentiation Antigens in the Peripheral Blood of Patients with Alopecia Areata Treated with Oral Zinc
February 1990
in “
PubMed
”
Studysummary This study found that zinc treatment in alopecia areata patients may increase CD8+ cells, suggesting its effectiveness could be due to immunomodulation.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the effects of oral zinc treatment on lymphocyte subpopulations in patients with alopecia areata (AA). It was found that hair regrowth in AA was linked to the normalization of the CD4+/CD8+ ratio, which was typically imbalanced with increased CD4+ and decreased CD8+ cells. Zinc, known as a polyclonal T-cell activator, was shown to significantly increase levels of CD3+, CD8+, CD19+, HLA-DQ+, HLA-DR+, and Leu 2a+8+ cells in the peripheral blood during treatment. The study concluded that zinc's effectiveness in treating AA might be due to its immunomodulatory effects, particularly through the increase of CD8+ cells.